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Abstract
Introduction Critically ill patients requiring intensive care
uniformly develop insulin resistance. This is most pronounced in
patients with sepsis. Recently, several hormones secreted by
adipose tissue have been identified to be involved in overall
insulin sensitivity in metabolic syndrome-related conditions.
However, little is known about these adipokines in critical illness.
Methods We studied circulating levels of the adipokines
adiponectin, retinol-binding protein 4 (RBP4), and leptin during
critical illness, and the impact of intensive insulin therapy, a
therapy shown to affect insulin sensitivity, in serum samples from
prolonged critically ill patients with a respiratory critical illness (n
= 318). For comparison, we studied healthy subjects (n = 22)
and acutely stressed patients (n = 22).
Results During acute critical illness, circulating levels of
adiponectin, RBP4, and leptin were low. Patients with sepsis
had lower levels of leptin and RBP4 than did nonseptic patients.
When critical illness was sustained, adipokine levels returned to
normal reference values. Insulin therapy enhanced adiponectin,
blunted the rise of RBP4, and did not alter leptin levels.
Conclusions Acute critical illness is associated with immediate,
but transiently low serum adipokine levels. Adiponectin and
RBP4 are associated with altered insulin resistance in critical
illness.
Introduction
Critically ill patients requiring intensive care uniformly develop
hyperglycemia in the presence of hyperinsulinemia, suggest-
ing insulin resistance. This is most pronounced in patients with
sepsis [1].
Recently, several hormones secreted by adipose tissue have
been identified to be involved in overall insulin sensitivity in
metabolic syndrome-related conditions. Adiponectin appears
to increase insulin sensitivity, with low levels observed in con-
ditions of insulin resistance, such as obesity and type 2 diabe-
tes, and with higher levels being associated with increased
insulin sensitivity [2,3]. Leptin and retinol-binding protein-4
(RBP4), the only specific transporter for retinol in the circula-
tion, appear to affect insulin action. Circulating levels of RBP4
are elevated in subjects with obesity and type 2 diabetes and
lower with improved insulin sensitivity [4,5]. Low leptin levels
are present with insulin resistance, and insulin infusion can
induce leptin secretion [6].
In insulin resistance of the critically ill, little is known about
these adipokines. Furthermore, the impact of insulin therapy
during critical illness on these adipokines has not been stud-
ied. We hypothesized that the insulin resistance that is present
in critical illness would affect circulating adiponectin, RBP4,
and leptin levels and that the improved insulin sensitivity that
we observed in intensive insulin therapy (IIT) patients [7]
would change the adipokine levels.
CIT: conventional insulin therapy; IIT: intensive insulin therapy; RBP4: retinol-binding protein 4.Critical Care    Vol 13 No 4    Langouche et al.
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Materials and methods
Study design
This study was a subanalysis of a large (n = 1,200) prospec-
tive, randomized controlled study on the effects of IIT on out-
come of critical illness [8]. The detailed protocol of the study
was previously published [8]. Written informed consent was
obtained from the closest family member. The protocol and
consent forms, including later analyses, were approved by the
Institutional Ethical Board. Patients randomly assigned to con-
ventional insulin therapy (CIT) received insulin only when glu-
cose concentrations exceeded 215 mg/dl, resulting in mean
blood glucose of 153 mg/dl (hyperglycemia). IIT maintained
blood glucose levels between 80 and 110 mg/dl, resulting in
mean blood glucose of 111 mg/dl (normoglycemia). Caloric
intake was not different between the two therapy groups. To
reduce the number of samples for the current study, we chose
to work with the largest homogeneous subset (43%) of the
1,200 originally included patients, identifiable on admission,
being the subset of 512 patients with a respiratory disease as
main reason for admission to the ICU. From those, we studied
the 318 patients requiring at least 5 days of intensive care to
assess the impact of IIT within the time frame that was required
to bring about clinical benefits (Table 1). In this selection of
long-stay respiratory patients, 100% of the patients assigned
to IIT received insulin during their ICU stay (mean daily insulin
dose, 83.1 ± 4.9 IU (mean ± SEM)), whereas 86.2% of the
patients assigned to CIT received insulin (mean daily insulin
dose, 25.3 ± 3.0 IU). In this selection of long-stay respiratory
patients, all baseline characteristics except age were compa-
rable in the two treatment populations (Table 1). IIT signifi-
cantly reduced maximal Sequential Organ Failure Assessment
(SOFA) score (indicating reduced organ failure), length of ICU
stay, and in-hospital mortality (Table 1); no difference was
seen in the cause of death in the ICU. For comparison, we
studied, after informed consent, 22 overnight-fasted healthy
volunteers (mean ± SD; age, 69 ± 8 years; BMI, 26.8 ± 3.5;
15 males), and 22 matched, not critically ill patients who
underwent elective abdominal surgery (mean ± SD; age, 69 ±
13 years; BMI, 25.1 ± 2.6; 14 males). Blood samples taken
from patients under acute surgical stress were obtained at the
end of the procedure, before skin closure. After sampling and
centrifugation, serum was kept frozen at -80°C until analysis.
The protocols for both control studies were approved by the
Institutional Ethical Board.
Circulating adiponectin, RBP4, and leptin
Serum total adiponectin was measured with time-resolved
immunofluorometric assay based on reagents from R&D Sys-
tems (Minneapolis, MN, USA). Serum RBP4 and serum leptin
were determined with ELISA (Phoenix Pharmaceuticals, Burl-
ingame, CA, USA) and RIA (Linco Research, Billerica, MA,
USA), respectively. For all assays the intra- and interassay
coefficients of variations (CVs) were less than 5% and 10%,
respectively.
Statistical analysis
The results were compared with unpaired Student's t-tests
and Mann-Whitney U tests. We used the χ2-test for compari-
son of proportions. The significance of correlations between
parameters was assessed by the Pearson (R) correlation coef-
Table 1
Baseline and outcome characteristics of critically ill patients (ICU stay ≥5 days)
CIT
(n = 152)
IIT
(n = 166)
P
Sex (number [percentage] male) 98 [64.5] 107 [64.5] >0.9
Age (years; mean ± SD) 69 ± 14 64 ± 15 0.008
BMI (mean ± SD) 24.2 ± 5.2 24.7 ± 5.1 0.5
Adm. Apache II score (median [IQR]) 23 [17.5–28.5] 22 [17–28] 0.4
Adm. SOFA score (median [IQR]) 7 [4–9] 6 [4–8] 0.3
Kidney failure on admission (number [percentage]) 23 [15.1] 23 [13.9] 0.7
History of diabetes (number [percentage]) 16 [10.5] 23 [13.9] 0.4
Blood glucose on admission (mg/dl; mean ± SD) 167 ± 68 165 ± 68 0.7
Maximum SOFA score during ICU stay (mean ± SD) 10.5 ± 4.5 9.7 ± 4.3 0.05
Days in ICU (median [IQR]) 14 [8–22] 10 [16–17] 0.008
Death in ICU (number [percentage]) 60 [39.5] 50 [30.1] 0.08
In-hospital deaths (number [percentage]) 90 [59.2] 71 [42.8] 0.003
Newly acquired kidney injury (number [percentage]) 23 [15.1] 16 [9.6] 0.1Available online http://ccforum.com/content/13/4/R112
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ficient. Statistical significance was considered when two-
sided P values were below or equal to 0.05. Stat View 5.0.1
was used.
Results
Circulating adiponectin, RBP4, and leptin levels in the critically
ill patients were low on admission to ICU as compared with
those in healthy subjects (Figure 1). For RBP4, 38%, and for
leptin, 27% of the admission values were below the lower limit
of the 95% confidence interval of the levels observed in
healthy volunteers. Patients undergoing elective surgery dem-
onstrated lower serum adiponectin, RBP4, and leptin than did
healthy controls (Figure 1). For RBP4, 20%, and for leptin,
24% of the values were below the lower limit of the 95% con-
fidence interval of the levels observed in healthy volunteers.
Critically ill patients with sepsis on ICU admission had even
lower circulating admission levels of RBP4 and leptin than did
patients without sepsis (Figure 1). Baseline patient character-
istics of septic versus nonseptic patients were not different,
except for the admission SOFA score (Table 2).
With time in ICU, circulating levels of all three adipokines
increased, although leptin remained low in septic patients
throughout their stay in the ICU (P = 0.007 for day 5; P = 0.06
for day 10; and P = 0.002 for the last day). Neither adiponec-
Figure 1
Circulating adipokines during critical illness Circulating adipokines during critical illness. (a-c) Impact of acute illness: Results from healthy volunteers, patients not critically ill undergoing elec-
tive surgery, and critically ill patients on admission to the ICU are presented as box plots (boxes are medians and interquartile ranges; whiskers are 
10th and 90th percentiles). (d-f) Critically ill patients who received CIT (white bars) or IIT (gray bars). Reference values (mean ± SEM) of healthy con-
trols are indicated by two horizontal dotted lines. Adm = admission day; D5 = day 5; D10 = day 10; LD = the last day of ICU stay; ICU = intensive 
care unit. Data are presented as mean ± SEM. *P ≤ 0.05; **P ≤ 0.01. For statistical analysis, we subtracted corresponding admission-day values, 
and for leptin, we used log-transformed data as indicated on the figure.Critical Care    Vol 13 No 4    Langouche et al.
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tin, leptin, nor RBP4 correlated significantly with the cytokines
IL-6, IL-8, IL-10, and TNF-α.
On all studied time points, adiponectin and leptin levels were
significantly higher in female subjects than in male subjects
(data not shown) and correlated with BMI (R = -0.194; P =
0.0002 for adiponectin; R = 0.456; P < 0.0001 for leptin). No
correlation was present between any of the studied adipokines
and age.
IIT further increased the serum levels of adiponectin, whereas
it blunted the rise of serum RBP4, with no effect on serum lep-
tin (Figure 1). Circulating RBP4 correlated positively with
serum creatinine levels throughout ICU stay (admission R =
0.363; day 5 R = 0.406; day 10 R = 0.584; last-day R =
0.475; P < 0.0001 for all). Serum leptin levels correlated pos-
itively with the corresponding circulating insulin levels (admis-
sion R = 0.373; day 10 R = 0.330; last-day R = 0.292; P <
0.0001 for all).
Discussion
We observed low circulating levels of adiponectin, RBP4, and
leptin in critically ill patients on admission to the ICU, with low-
est values in patients with sepsis, but also in patients not crit-
ically ill under acute surgical stress. These observations would
suggest an acute stress response. Low levels of circulating
RBP4 and leptin were previously observed after burn injury or
trauma or both [9,10], and low levels of adiponectin were
reported in rats with sepsis [11]. It is unclear what mediates
this acute lowering with stress. Theoretically, reduced synthe-
sis or increased removal, or both, either by extravasation or by
increased metabolic clearance, may play a role. The lower val-
ues in patients with sepsis would suggest the former, as this
condition is characterized by capillary leakage, which could
have removed the adipokines to the interstitial compartment.
The low adipokine levels might in part be a consequence of the
inactivity and malnourished status of the medical intensive
care patients on admission to the ICU and of the overnight
fasting of the patients undergoing elective surgery. Fasting
reduces leptin levels [12], and severe calorie restriction with
weight loss reduces circulating RBP4 [13]. However, an
increase in circulating adiponectin levels would be expected
[14], and thus, this cannot explain the changes in the ICU
patients, particularly because the healthy volunteers were
fasted overnight.
We found adiponectin and leptin levels to be higher in women
than in men and correlating with the BMI. This gender differ-
ence has been related to the difference in sex steroids and to
the higher ratio of subcutaneous to omental fat mass in women
[15].
IIT targeted to normoglycemia further increased the rise of
serum adiponectin with time in the ICU. This corresponds with
the altered insulin sensitivity that has been associated with
better glycemic control in patients with type 2 diabetes
[16,17], but also in critically ill patients treated with IIT [2,7].
IIT blunted the rise in serum RBP4 that occurs with time in
ICU. Decreasing levels of RBP4 were associated previously
with altered insulin resistance [4,5]. Euglycemia with insulin
therapy in severely burned children also decreased circulating
RBP4 [18]. However, some contrasting results were reported
Table 2
Baseline and outcome characteristics of septic versus nonseptic critically ill patients (ICU stay ≥5 days)
Proven sepsis (n = 165) Proven no sepsis (n = 94) P
Sex (number [percentage] male]) 111 [67.3] 59 [62.8] 0.5
Age (years; mean ± SD) 66.1 ± 12.3 67.0 ± 15.2 0.6
BMI (mean ± SD) 25.1 ± 5.1 24.1 ± 5.0 0.1
Admission Apache II score (median [IQR]) 23 [17–29] 21 [17–28] 0.6
Admission SOFA score (median [IQR]) 7 [4–9] 4 [3–7] < 0.0001
Kidney failure on admission (number [percentage]) 27 [16.3] 12 [12.8] 0.4
History of diabetes (number [percentage]) 20 [12.1] 15 [16.0] 0.4
Blood glucose on admission (mg/dl; mean ± SD) 164.5 ± 66.6 166.7 ± 70.3 0.8
Maximum SOFA score during ICU stay (mean ± SD) 9.4 ± 4.0 7.1 ± 3.7 < 0.0001
Days in ICU (median [IQR]) 12 [7–20] 12.5 [7–19] 0.5
Death in ICU (number [percentage]) 54 [32.7] 24 [25.5] 0.2
In-hospital deaths (number [percentage]) 85 [51.5] 41 [43.6] 0.2
All subjects were screened for infection on admission and were defined retrospectively for this post hoc study as "proven sepsis" when infection 
was proven and the Bone criteria were fulfilled [29]. Patients proven not to have sepsis with this strict definition were classified as "proven no 
sepsis". Fifty-nine patients for whom treatment with antibiotics was started before admission to the ICU were categorized as unknown and 
therefore excluded from this subanalysis.Available online http://ccforum.com/content/13/4/R112
Page 5 of 6
(page number not for citation purposes)
regarding the association between circulating RBP4 and insu-
lin resistance [19,20]. Furthermore, increased levels of circu-
lating RBP4 have been described in patients with chronic
renal failure and attributed to reduced glomerular filtration
[21].
In our setting, IIT improved kidney function [8,22], and circulat-
ing RBP4 levels correlated with creatinine levels. Leptin levels
are known to correlate with reduced insulin sensitivity, and
insulin infusion can induce leptin secretion [6,23]. However,
IIT failed to change leptin levels throughout the ICU stay. This
can be explained by the observation that, although several-fold
higher insulin doses were required to maintain normoglycemia
with IIT, serum insulin levels were equal between the two ther-
apy groups [24] and correlated well with leptin at all studied
time points. Furthermore, it was reported that C-reactive pro-
tein, which reaches very high levels in critical illness, inhibits
leptin binding to its receptor and blocks cellular signaling [25].
We must highlight two shortcomings in our study. As we stud-
ied only those patients with a respiratory disease as the main
reason for admission to the ICU, extrapolation of our results to
other diagnostic categories should be done with great caution.
We studied adipokine levels only in prolonged critically ill
patients, as our primary objective was to assess the role of the
studied adipokines on the impact of IIT within the time frame
that was required to bring about clinical benefits. Hence, an
early effect may have been missed in this study. Earlier studies
on leptin levels in the acute phase (first 24 hours) of sepsis
describe a sepsis-induced elevation in leptin [26-28]. The ele-
vation does not appear to be driven by the severity of illness,
as survivors showed higher levels than did nonsurvivors [26-
28]. These results and the observations that diet, insulin, BMI,
gender, and cytokines may affect leptin levels make it clear
that the role of leptin in critical illness remains incompletely
understood.
Conclusions
Acute stress, caused by surgery or by critical illness of pulmo-
nary origin, was associated with immediate but transiently low
serum adiponectin, leptin, and RBP4 levels. Sepsis especially
reduced RBP4 and leptin levels. IIT accentuated the rise of cir-
culating adiponectin levels occurring with time in the ICU,
blunted the rise of RBP4, and did not alter leptin levels. The
effects of IIT on adiponectin and RBP4 are indicative of altered
insulin sensitivy with IIT in the ICU patients.
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